Omnicell, Inc. · NASDAQ:OMCL

Omnicell — FY2020 Earnings Presentation

10 slides from Omnicell's earnings presentation, Feb 1, 2021

  1. Slide 1: 2020 Fiscal Year and Fourth Quarter Earnings Call

    2020 Fiscal Year and Fourth Quarter Earnings Call February 1, 2021

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements 2 This presentation contains “forward-looking statements” within the meaning of federal securities laws. These forward-looking statements include statements with respect to the 2021 and 2025 targets, growth targets and other expectations and other non-historical informatio

  3. Slide 3: Resilient and High-Visibility Revenue

    Resilient and High-Visibility Revenue 3 Robust Backlog Robust product backlog 145 of the top 300 U.S. health systems in long-term, sole-source agreements1,2 99%+ customer retention3 36% through XT series replacement cycle2 Point of Care Installed Base Early in Upgrade Cycle Deep Customer Relationshi

  4. Slide 4: Advanced Services Accelerating Recurring Revenue Growth

    Advanced Services Accelerating Recurring Revenue Growth 4 SaaS, Subscription Software & Tech-Enabled Services (% of Total Revenue) 6% 2020 20-30% 2025E  Leveraging established channel and strong customer relationships  Strong demand driven by increasing provider digitization and need to evolve med

  5. Slide 5: Driving Profitable Growth Through Disciplined Execution

    Driving Profitable Growth Through Disciplined Execution 5 $1,900-$2,000 2025E $1,085-$1,105 2021E Expected Annual Revenue ($ in Millions) © 2021 Omnicell, Inc. $1,650-$1,750 Continue to grow and expand within large existing customer base (sites & product) Capitalize on upgrade cycles Continue market

  6. Slide 6: Continuing to Drive Margin Expansion

    Continuing to Drive Margin Expansion 6 13% 2020 Targeted Non-GAAP Operating Margin (%) Targeted Non-GAAP EBITDA Margin (%) ~21% 2025E 18% 2020 ~25% 2025E  Improving Business Mix – SaaS, Subscription Software & Tech-Enabled Services targeted to represent 20-30% of revenue by 2025, supporting strong

  7. Slide 7: Appendix

    Appendix 7

  8. Slide 8: Reconciliation of GAAP to Non-GAAP

    8© 2021 Omnicell, Inc. Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Reconciliation of GAAP gross profit to non-GAAP gross profit: GAAP gross profit $ 123,6

  9. Slide 9: Reconciliation of GAAP to Non-GAAP

    9© 2021 Omnicell, Inc. Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) Three Months Ended December 31, Year Ended December 31, 2020 2019 2020 2019 Reconciliation of GAAP net income to non-GAAP net income: GAAP net income $ 16,377 $ 22

  10. Slide 10: Slide 10

OMNICELL — FY2020 Earnings Presentation on 6ix